Safety and Immunogenicity of Heterologous Prime-Boost with the Candidate Malaria Vaccines AdCh63 ME-TRAP and MVA ME- TRAP in Healthy Adults in a Malaria Endemic Area.
Phase of Trial: Phase I
Latest Information Update: 13 Sep 2016
At a glance
- Drugs ME-TRAP malaria DNA vaccine Okairos (Primary)
- Indications Malaria
- Focus Adverse reactions
- 14 Mar 2012 Status changed from active, no longer recruiting to completed as reported by Pan-African Clinical Trials Registry.
- 20 Sep 2011 New trial record